All News #Library
Rare Diseases
PepGen Stock Halves on Mixed Data in Rare Muscle Disease
31 Mar 2026 //
BIOSPACE
PepGen Receives U.S. FDA Orphan Drug Designations for PGN-EDO51
13 Mar 2024 //
GLOBENEWSWIRE

Market Place
Sourcing Support